Defining endogenous DMT brain biotypes through a multimodal neuroimaging study of serotonin signaling, consciousness traits, and individual neural variation

Endogenous DMT is the focus of a multimodal neuroimaging proposal that aims to identify brain biotypes linked to naturally occurring DMT signaling, serotonin system variation, and differences in conscious experience. The work centers on whether measurable neural signatures associated with endogenous DMT can help explain stable individual differences in perception, cognition, and consciousness-related traits. Multimodal imaging is positioned as the main method for integrating brain structure, function, and neurochemical markers. Serotonergic mechanisms appear central to the framing, with DMT treated as a candidate endogenous modulator whose role in the human brain remains uncertain but potentially important. Brain biotypes could offer a way to classify people by neurobiological patterns rather than broad behavioral categories alone. That framing matters because it could connect psychedelic science, consciousness research, and biomarker discovery while clarifying whether endogenous DMT has a meaningful role in normal brain function.